| Maura Elizabeth Buse, PHARM D | |
|
12661 Olive Blvd, Creve Coeur, MO 63141-6333 | |
| (314) 878-4413 | |
| (314) 878-8055 |
| Full Name | Maura Elizabeth Buse |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 12661 Olive Blvd, Creve Coeur, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568744266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2010022986 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maura Elizabeth Buse, PHARM D 12661 Olive Blvd, Creve Coeur, MO 63141-6333 Ph: (314) 878-4413 | Maura Elizabeth Buse, PHARM D 12661 Olive Blvd, Creve Coeur, MO 63141-6333 Ph: (314) 878-4413 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
Statins, used widely to treat elevated cholesterol, have been shown to prevent progression of coronary narrowing and to have other beneficial effects on the heart, such as reducing inflammation, that are independent of cholesterol.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the continued expansion of its clinical trial site alliance network, an extensive network of investigator sites and Site Management Organizations (SMOs) that enables PAREXEL to quickly access and enroll patient populations for clients' clinical trials worldwide.
OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery.
A rare but fatal disease of blood vessels in the lung may be caused in part by aberrant silencing of genes rather than genetic mutation, new research reports. Pulmonary arterial hypertension, a syndrome characterized by gradual blockage of blood vessels in the lungs, has been linked to genetic causes in a small percentage of patients. But University of Chicago researchers have now found that a form of epigenetics - the modification of gene expression - causes the disease in an animal model and could contribute to the disease in humans.
› Verified 9 days ago
Alex Gitman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10941 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-997-0555 | |
Randall Scott Piper, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12661 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-878-4413 | |
Dr. Stephanie Denise Ipock, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10941 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-997-0555 | |
Dr. Brittany Lynn Gisi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12661 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-878-4413 Fax: 314-878-8055 | |
Clayton Nelson Brown, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10420 Old Olive Street Rd, Suite 103, Creve Coeur, MO 63141 Phone: 314-736-5555 | |
Jeffrey Juang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10941 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-997-0555 | |
Dr. Zachary Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11560 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-995-7128 |